Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Gliovac |
Trade Name | |
Synonyms | ERC1671|ERC 1671|ERC-1671|Sitoiganap |
Drug Descriptions |
Gliovac (ERC 1671) is a glioblastoma vaccine comprising autologous tumor-derived antigens and allogeneic tumor-derived antigens, which may induce an anti-tumor immune response (PMID: 25865468, PMID: 30157683). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C107502 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gliovac | Gliovac | 0 | 0 |
Gliovac + Sargramostim | Gliovac Sargramostim | 0 | 0 |